[Advanced prostatic cancer: therapeutic modalities].
D000135:Acid Phosphatase / Q000378:metabolism; D000970:Antineoplastic Agents / Q000627:therapeutic use*; D001971:Bromocriptine / Q000627:therapeutic use; D002369:Castration; D003131:Combined Modality Therapy; D003534:Cyproterone / Q000627:therapeutic use; D004961:Estramustine / Q000627:therapeutic use; D004967:Estrogens / Q000627:therapeutic use*; D005472:Fluorouracil / Q000627:therapeutic use; D006801:Humans; D008090:Lisuride / Q000627:therapeutic use; D008297:Male; D009362:Neoplasm Metastasis; D011471:Prostatic Neoplasms / Q000188:drug therapy*; D011897:Random Allocation
D000970:Antineoplastic Agents; D004967:Estrogens; D004961:Estramustine; D001971:Bromocriptine; D008090:Lisuride; D003534:Cyproterone; D000135:Acid Phosphatase; D005472:Fluorouracil
Das fortgeschrittene Prostatakarzinom: therapeutische Modalitäten.